Lista de obras - Sophie Tartare-Deckert - Dominio Público Uruguay

A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment

artículo científico publicado en 2021

A feed-forward mechanosignaling loop confers resistance to therapies targeting the MAPK pathway in BRAF-mutant melanoma

scientific article published on 16 March 2020

A non-coding function of TYRP1 mRNA promotes melanoma growth.

artículo científico publicado en 2017

Blockade of the pro-fibrotic reaction mediated by the miR-143/-145 cluster enhances the responses to targeted therapy in melanoma

scientific article published on 14 February 2022

Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages

artículo científico publicado en 2015

Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma

artículo científico publicado en 2017

Dual roles of p300 in chromatin assembly and transcriptional activation in cooperation with nucleosome assembly protein 1 in vitro

artículo científico publicado en 2002

Gene expression profiling of normal human pulmonary fibroblasts following coculture with non-small-cell lung cancer cells reveals alterations related to matrix degradation, angiogenesis, cell growth and survival

article

HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1.

artículo científico publicado en 2005

Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells

artículo científico publicado en 2011

Identification by mutation of the tyrosine residues in the insulin receptor substrate-1 affecting association with the tyrosine phosphatase 2C and phosphatidylinositol 3-kinase

artículo científico publicado en 1995

In vitro and in vivo anti-melanoma effects of ciglitazone.

artículo científico publicado en 2009

LIF mediates proinvasive activation of stromal fibroblasts in cancer

artículo científico publicado en 2014

Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation

artículo científico publicado en 2003

Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner.

artículo científico publicado en 2013

Metformin inhibits melanoma development through autophagy and apoptosis mechanisms.

artículo científico publicado en 2011

Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in microglia recruitment

artículo científico publicado en 2004

Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARC.

artículo científico publicado en 2010

Prostaglandin E2 induces interaction between hSlo potassium channel and Syk tyrosine kinase in osteosarcoma cells.

artículo científico publicado en 2002

Regulation of secreted protein acidic and rich in cysteine during adipose conversion and adipose tissue hyperplasia.

artículo científico publicado en 2006

Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1

scientific article published on 23 January 2020

Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays

artículo científico publicado en 2014

SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness

artículo científico publicado en 2015

SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.

artículo científico publicado en 2011

SPARC represses E-cadherin and induces mesenchymal transition during melanoma development

artículo científico publicado en 2006

Simalikalactone E (SkE), a new weapon in the armamentarium of drugs targeting cancers that exhibit constitutive activation of the ERK pathway

artículo científico publicado en 2012

Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest

artículo científico publicado en 2009

Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma

artículo científico publicado en 2021

Technical advance: actin CytoFRET, a novel FRET flow cytometry method for detection of actin dynamics in resting and activated T cell.

artículo científico publicado en 2013

The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion

artículo científico publicado en 2012

The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity.

artículo científico

The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression.

artículo científico publicado en 2010

The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.

artículo científico publicado en 2009

Tumor-Derived Fibronectin Is Involved in Melanoma Cell Invasion and Regulated by V600E B-Raf Signaling Pathway

artículo científico publicado en 2006

Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis

artículo científico publicado en 2015

Vav1 couples T cell receptor to serum response factor-dependent transcription via a MEK-dependent pathway

artículo científico publicado en 2002

Vav2 activates c-fos serum response element and CD69 expression but negatively regulates nuclear factor of activated T cells and interleukin-2 gene activation in T lymphocyte

artículo científico publicado en 2001

[Melanoma therapeutic escape: the biomechanical track]

artículo científico publicado en 2020

Lista de obras de Sophie Tartare-Deckert

A 9-kDa matricellular SPARC fragment released by cathepsin D exhibits pro-tumor activity in the triple-negative breast cancer microenvironment

A feed-forward mechanosignaling loop confers resistance to therapies targeting the MAPK pathway in BRAF-mutant melanoma

A non-coding function of TYRP1 mRNA promotes melanoma growth.

Blockade of the pro-fibrotic reaction mediated by the miR-143/-145 cluster enhances the responses to targeted therapy in melanoma

Cherubism allele heterozygosity amplifies microbe-induced inflammatory responses in murine macrophages

Comparative oncogenomics identifies tyrosine kinase FES as a tumor suppressor in melanoma

Dual roles of p300 in chromatin assembly and transcriptional activation in cooperation with nucleosome assembly protein 1 in vitro

Gene expression profiling of normal human pulmonary fibroblasts following coculture with non-small-cell lung cancer cells reveals alterations related to matrix degradation, angiogenesis, cell growth and survival

HGF induces fibronectin matrix synthesis in melanoma cells through MAP kinase-dependent signaling pathway and induction of Egr-1.

Hypoxia and MITF control metastatic behaviour in mouse and human melanoma cells

Identification by mutation of the tyrosine residues in the insulin receptor substrate-1 affecting association with the tyrosine phosphatase 2C and phosphatidylinositol 3-kinase

In vitro and in vivo anti-melanoma effects of ciglitazone.

LIF mediates proinvasive activation of stromal fibroblasts in cancer

Matrix metalloproteinases are differentially expressed in adipose tissue during obesity and modulate adipocyte differentiation

Metformin blocks melanoma invasion and metastasis development in AMPK/p53-dependent manner.

Metformin inhibits melanoma development through autophagy and apoptosis mechanisms.

Pathological prion protein exposure switches on neuronal mitogen-activated protein kinase pathway resulting in microglia recruitment

Persistent activation of the Fyn/ERK kinase signaling axis mediates imatinib resistance in chronic myelogenous leukemia cells through upregulation of intracellular SPARC.

Prostaglandin E2 induces interaction between hSlo potassium channel and Syk tyrosine kinase in osteosarcoma cells.

Regulation of secreted protein acidic and rich in cysteine during adipose conversion and adipose tissue hyperplasia.

Resistance of melanoma to immune checkpoint inhibitors is overcome by targeting the sphingosine kinase-1

Risk for nevus transformation and melanoma proliferation and invasion during natalizumab treatment: four years of dermoscopic follow-up with immunohistological studies and proliferation and invasion assays

SIGMAR1 Regulates Membrane Electrical Activity in Response to Extracellular Matrix Stimulation to Drive Cancer Cell Invasiveness

SPARC functions as an anti-stress factor by inactivating p53 through Akt-mediated MDM2 phosphorylation to promote melanoma cell survival.

SPARC represses E-cadherin and induces mesenchymal transition during melanoma development

Simalikalactone E (SkE), a new weapon in the armamentarium of drugs targeting cancers that exhibit constitutive activation of the ERK pathway

Spleen tyrosine kinase functions as a tumor suppressor in melanoma cells by inducing senescence-like growth arrest

Targeting Discoidin Domain Receptors DDR1 and DDR2 overcomes matrix-mediated tumor cell adaptation and tolerance to BRAF-targeted therapy in melanoma

Technical advance: actin CytoFRET, a novel FRET flow cytometry method for detection of actin dynamics in resting and activated T cell.

The epithelial-mesenchymal transition (EMT) regulatory factor SLUG (SNAI2) is a downstream target of SPARC and AKT in promoting melanoma cell invasion

The matricellular protein SPARC/osteonectin as a newly identified factor up-regulated in obesity.

The p53/p21Cip1/ Waf1 pathway mediates the effects of SPARC on melanoma cell cycle progression.

The tyrosine kinase Syk regulates the survival of chronic lymphocytic leukemia B cells through PKCdelta and proteasome-dependent regulation of Mcl-1 expression.

Tumor-Derived Fibronectin Is Involved in Melanoma Cell Invasion and Regulated by V600E B-Raf Signaling Pathway

Tumour-derived SPARC drives vascular permeability and extravasation through endothelial VCAM1 signalling to promote metastasis

Vav1 couples T cell receptor to serum response factor-dependent transcription via a MEK-dependent pathway

Vav2 activates c-fos serum response element and CD69 expression but negatively regulates nuclear factor of activated T cells and interleukin-2 gene activation in T lymphocyte

[Melanoma therapeutic escape: the biomechanical track]